Short Interest in Viva Biotech Holdings (OTCMKTS:VBIZF) Increases By 3,650.0%

Viva Biotech Holdings (OTCMKTS:VBIZF) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 75,000 shares, a growth of 3,650.0% from the April 30th total of 2,000 shares. Based on an average daily volume of 909 shares, the short-interest ratio is presently 82.5 days.

Viva Biotech Price Performance

VBIZF opened at $0.20 on Thursday. Viva Biotech has a 1-year low of $0.20 and a 1-year high of $0.20. The business has a 50 day moving average of $0.30 and a 200-day moving average of $0.29.

About Viva Biotech

Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.

With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.